By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen today said that it has established a subsidiary in New Delhi, India, to sell its products directly to the Indian market.

The firm had been using distributors for its products in the country, but it believes setting up the new subsidiary will further its growth in the emerging market.

Qiagen expects the New Delhi office will have more than 30 employees by the end of this year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.